newsfilter
← Latest News
GlobeNewswire·

Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary